Your browser doesn't support javascript.
loading
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Myers, Sara P; Sevilimedu, Varadan; Jones, V Morgan; Abuhadra, Nour; Montagna, Giacomo; Plitas, George; Morrow, Monica; Downs-Canner, Stephanie M.
Affiliation
  • Myers SP; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sevilimedu V; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Jones VM; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Abuhadra N; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Montagna G; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Plitas G; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Morrow M; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Downs-Canner SM; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. downscas@mskcc.org.
Ann Surg Oncol ; 31(8): 4950-4951, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38833059

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoadjuvant Therapy / Triple Negative Breast Neoplasms Limits: Female / Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoadjuvant Therapy / Triple Negative Breast Neoplasms Limits: Female / Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2024 Type: Article Affiliation country: United States